Recruiting NA Silent Brain Infarction

New treatment option for Silent Brain Infarction

Official title Interventions for Silent Brain Infarction and Perioperative Neurocognitive Disorders in Cardiovascular Surgery

ClinicalTrials.gov ID: NCT07048002

What this study is testing

What it's testing
the purpose of the study is to investigate whether a combined anesthetic targets bundle, known as the NeuroFirst strategy, focused on neurological protection, can reduce the incidence of silent brain infarction (SBI) and perioperative neurocognitive disorders (PND) in patients undergoing cardiac surgery. Additionally, the trial will assess the safety of this strategy.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 60 and older

You may be able to join if

  • Male or female adult patients aged 60 years or older
  • Receiving elective cardiovascular surgery with cardiopulmonary bypass
  • Written Informed consent provided

You likely can't join if

  • Contraindication to MRI scanning
  • Not suitable for receiving interventions to achieve NeuroFirst target bundle
  • Unable to receive neuro-cognitive evaluation due to language, vision, or hearing impairments
  • Breastfeeding or pregnancy
  • Terminal illness with a life expectancy of less than 3 months
  • Mental or legal disability
See the full eligibility criteria
Who can join
  • Male or female adult patients aged 60 years or older
  • Receiving elective cardiovascular surgery with cardiopulmonary bypass
  • Written Informed consent provided
What rules you out
  • Contraindication to MRI scanning
  • Not suitable for receiving interventions to achieve NeuroFirst target bundle
  • Unable to receive neuro-cognitive evaluation due to language, vision, or hearing impairments
  • Breastfeeding or pregnancy
  • Terminal illness with a life expectancy of less than 3 months
  • Mental or legal disability
  • current enrollment in other treatment study

The study team makes the final eligibility decision.

Where it's taking place

  • Beijing, Beijing Municipality, China
  • Wuhan, Hubei, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Beijing, Beijing Municipality, China; Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.